Reliance Industries Rights Issue Gains 15% A Day After Stellar Debut
- Reliance Industries-Rights Entitlement ended the day higher by Rs 30Â or 14.77Â per cent at Rs 232Â on the NSE.
- On 30 April, the board of Reliance Industries had approved the country's biggest rights issue of up to Rs 53,125 crore at Rs 1,257 per share at a share ratio of 1:15 and fixed May 14 as the record date.
- One share would be offered for every 15 shares held, at Rs 1,257, amounting to a 14 per cent discount to the closing price on April 30.
- A rights issue grants shareholders the right, but not an obligation, to buy new shares in the rights offerings at a discount to the existing trading price.
- The rights issue is the first of its kind for Reliance Industries in almost 30 years. In 1991, the company had issued convertible debentures to raise funds from the public. The last time Reliance tapped the public for funds was in 1991 when it had issued convertible debentures. The debentures were subsequently converted into equity shares at Rs 55 apiece.
- Companies usually take the rights issue route to raise money. But for Reliance, it is not about raising funds as it has significant liquidity.
- The rights issue is a part of Reliance Industries' strategy of deleveraging its balance sheet to become a zero net debt. It is also an attempt to reward the shareholders and underscore promoters' faith in the Reliance growth story, say analysts.
- The promoter Ambani family has under-written the entire rights issue, pledging to buy shares that are unsubscribed.
- Reliance Industries chairman Mukesh Ambani had in August last year unveiled plans to cut debt to zero by 2021.
- As part of this plan, RIL has been seeking strategic partnerships across its businesses while targeting to deleverage the balance sheet.
-
Getting To Work Costs Women More | The Reason Why
It is not just about women paying more than men. It is about women paying much more in cities than in villages.
-
AI Bias In Investing Cannot Be Eliminated, But It Can Be Governed
Framing is a particularly important example as identical financial information presented in terms of gains rather than losses can lead an LLM to reach a different assessment.
-
Joining The Dots | Dark Skies, Steady Diya: Why Hope Holds This Diwali
With war, a weak rupee and foreign outflows weighing on sentiment, policymakers at the NDTV World Summit and market veterans at NDTV Profit Ignite: Diwali Edition offered the same advice: stay invested and filter out the noise.
-
The Curious Case of Equitas Small Finance Bank And A CEO Who Quit For Stock
PN Vasudevan believes persistent investor concerns over a perceived conflict of interest had become a governance overhang on Equitas Small Finance Bank's stock, even as the lender improved profitability and asset quality.
-
Talking Points This Week: AI Cash Burn, A Tiger Comeback And An India That Still Finds Its Own Path
India is not immune to higher oil or tighter global liquidity, yet its earnings base is broader, its domestic policy levers are still available.
-
Foreign Investors Own Half Of HDFC Bank and ICICI Bank. An LTCG Cut Could Matter Most Here
Foreign portfolio investors have US$115 billion parked in HDFC Bank, ICICI Bank. If the government cuts long-term capital gains tax, Jefferies says returning foreign money could land here first.
-
'Never Seen This Level Of Negativity': Sandeep Tandon Says The Next Rally May Be Closer Than You Think
Veteran investor Sandeep Tandon says foreign selling is easing, large-caps are due a comeback and mid-caps are crowded, while he turns positive on gold, power and pharma this Diwali.
-
Indians Stay With Family, Not In Hotels | The Reason Why
India still lacks enough clean, reliable and affordable hotels for budget-conscious travellers.
-
The Economic Imperative: Analysing The Material Driving Force Behind India-Canada Strategic Reset
This economic complementarity is further reinforced by deep institutional investment ties and talent mobility, which form the bedrock of the bilateral framework.
-
Medicine Pricing: Where Must Profit Stop?
India must confront excessive margins, hidden incentives and regulatory gaps that threaten the integrity of medicine.
